Journal Information
Review
Full text access
What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events
Article
This article is available in English
What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events
Jesus Miranda Poma, Lorena Ostios Garcia, Julia Villamayor Sanchez, Gabriele D’errico
10.1016/j.aller.2018.04.005Allergol Immunopathol (Madr). 2019;47:303-8